Literature DB >> 20219879

Additional seasonal influenza virus vaccinations for the 2009 H1N1 pandemic.

Cheng-Feng Qin, Tao Jiang, Jian-Feng Han, Xiao-Feng Li, E-De Qin, Qi-Bin Leng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20219879      PMCID： PMC2863379          DOI： 10.1128/CVI.00003-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


× No keyword cloud information.
  9 in total

1.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Scott A Harper; Keiji Fukuda; Timothy M Uyeki; Nancy J Cox; Carolyn B Bridges
Journal:  MMWR Recomm Rep       Date:  2004-05-28

2.  Serum Antibody Response to the Novel Influenza A (H1N1) Virus in the Elderly.

Authors:  Tao Jiang; Xiaofeng Li; Wei Liu; Man Yu; Juan Liu; Xuedong Yu; Ede Qin; Wuchun Cao; Qibin Leng; Chengfeng Qin
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

3.  Poverty, wealth, and access to pandemic influenza vaccines.

Authors:  Tadataka Yamada
Journal:  N Engl J Med       Date:  2009-08-12       Impact factor: 91.245

Review 4.  Haemagglutination-inhibiting antibody to influenza virus.

Authors:  J C de Jong; A M Palache; W E P Beyer; G F Rimmelzwaan; A C M Boon; A D M E Osterhaus
Journal:  Dev Biol (Basel)       Date:  2003

5.  Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2009-08-28

6.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Authors:  Kathy Hancock; Vic Veguilla; Xiuhua Lu; Weimin Zhong; Eboneé N Butler; Hong Sun; Feng Liu; Libo Dong; Joshua R DeVos; Paul M Gargiullo; T Lynnette Brammer; Nancy J Cox; Terrence M Tumpey; Jacqueline M Katz
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

7.  Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City.

Authors:  Lourdes Garcia-Garcia; Jose Luis Valdespino-Gómez; Eduardo Lazcano-Ponce; Aida Jimenez-Corona; Anjarath Higuera-Iglesias; Pablo Cruz-Hervert; Bulmaro Cano-Arellano; Antonio Garcia-Anaya; Elizabeth Ferreira-Guerrero; Renata Baez-Saldaña; Leticia Ferreyra-Reyes; Samuel Ponce-de-León-Rosales; Celia Alpuche-Aranda; Mario Henry Rodriguez-López; Rogelio Perez-Padilla; Mauricio Hernandez-Avila
Journal:  BMJ       Date:  2009-10-06

8.  Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines.

Authors:  Jennifer C Woo; Christopher S Ambrose
Journal:  Influenza Other Respir Viruses       Date:  2009-11       Impact factor: 4.380

9.  Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

Authors:  Takeshi Ichinohe; Shin-Ichi Tamura; Akira Kawaguchi; Ai Ninomiya; Masaki Imai; Shigeyuki Itamura; Takato Odagiri; Masato Tashiro; Hidehiro Takahashi; Hirofumi Sawa; William M Mitchell; David R Strayer; William A Carter; Joe Chiba; Takeshi Kurata; Tetsutaro Sata; Hideki Hasegawa
Journal:  J Infect Dis       Date:  2007-10-05       Impact factor: 5.226
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.